Placebo tablets will be the same size clinical trials

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of LY4100511 (DC-853) for the Treatment of Adult Participants with Moderate-to-Severe Plaque Psoriasis

This study is testing a new medicine, LY4100511, for adults with moderate to severe plaque psoriasis. It's a Phase 2 trial, meaning it's an early stage to see how well the medicine works and if it's safe, compared to a dummy pill.